Endovascular treatment of right ventricular tumor.

Primary cardiac tumors are rare, with the incidence between 0.17% and 0.19% in unselected autopsy series.1,2 After myxoma, cardiac fibroma is the second most common type of benign primary cardiac tumor.1,3 Untreated, cardiac fibroma has a poor prognosis, with death occurring in up to 25% of patients, usually the result of sudden death from conduction disturbances.1,3 Surgical extirpation is considered to be the treatment of choice but is associated with high morbidity and mortality in the early (10%) and late (4%) recovery periods.4 In the present report, we describe a novel endovascular treatment for right ventricular (RV) fibrolipoma with successful outcome.